88760741 - ORIONIS

Information

  • Trademark
  • 88760741
  • Serial Number
    88760741
  • Filing Date
    January 15, 2020
    4 years ago
  • Transaction Date
    February 12, 2024
    8 months ago
  • Status Date
    February 12, 2024
    8 months ago
  • Location Date
    February 12, 2024
    8 months ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED
    Employee Name
    FARRELL, ANNE M
  • Attorney Docket Number
    114384-0005
    Attorney Name
    Rachelle A. Dubow, Esq.
    Law Office Assigned Location Code
    M90
  • Owners
Mark Drawing Code
4000
Mark Identification
ORIONIS
Case File Statements
  • GS0051: Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; cytokines, namely, reagents for scientific and research use; pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
  • PM0001: ORION IS
  • GS0011: Diagnostic, biological and chemical reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
  • GS0421: Development of new technology for others in the field of biotechnology; scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; biotechnical research; technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of pharmaceuticals for others; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism
Case File Event Statements
  • 2/12/2024 - 8 months ago
    22 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/12/2024 - 8 months ago
    21 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 10/27/2023 - a year ago
    20 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 10/27/2023 - a year ago
    19 - FINAL REFUSAL E-MAILED Type: GNFR
  • 10/27/2023 - a year ago
    18 - FINAL REFUSAL WRITTEN Type: CNFR
  • 9/27/2023 - a year ago
    17 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 1/31/2023 - a year ago
    16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 6/1/2022 - 2 years ago
    15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 10/29/2021 - 3 years ago
    14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 4/23/2021 - 3 years ago
    13 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 8/10/2020 - 4 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 8/10/2020 - 4 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 8/10/2020 - 4 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 7/20/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/20/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/20/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/25/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/25/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/25/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/24/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/22/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/18/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP